KalVista names Brian Piekos as CFO
PremiumThe FlyKalVista names Brian Piekos as CFO
2M ago
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
Premium
Company Announcements
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
2M ago
Is ELTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is ELTX a Buy, Before Earnings?
3M ago
Elicio Therapeutics announces offering of common stock, no amount given
PremiumThe FlyElicio Therapeutics announces offering of common stock, no amount given
5M ago
Elicio Therapeutics reports inducement grants
Premium
The Fly
Elicio Therapeutics reports inducement grants
5M ago
Elicio Therapeutics files $200M mixed securities shelf
Premium
The Fly
Elicio Therapeutics files $200M mixed securities shelf
5M ago
Elicio Therapeutics to present ELI-002 trial in progress poster
PremiumThe FlyElicio Therapeutics to present ELI-002 trial in progress poster
10M ago
Elicio Therapeutics price target raised to $11 from $10 at H.C. Wainwright
Premium
The Fly
Elicio Therapeutics price target raised to $11 from $10 at H.C. Wainwright
10M ago
Elicio announces first patient dosed in Phase 2 study of ELI-002
Premium
The Fly
Elicio announces first patient dosed in Phase 2 study of ELI-002
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100